Krisianne Mae L.

Francisco
BSN III – B (group B3)

DRUG STUDY
USES
DRUG NAME ACTION INDICATION SIDE EFFECTS ADVERSE REACTION NURSING RESPONSIBLITIES

 naproxen Treatment of  Reduces To relieve mild Frequent (9%–4%): Rare reactions with long-term use Baseline Assessment
acute or inflammatory to moderate Nausea, constipation, include peptic ulcer, GI bleeding, Assess onset, type, location, duration
Drug long-term abdominal cramps/pain, gastritis, severe hepatic reactions of pain/inflammation. Inspect
response, intensity musculoskeletal
Classification: mild to appearance of affected joints for
of pain. inflammation, heartburn, dizziness, (cholestasis, jaundice),
 NSAID moderate immobility, deformities, skin
pain in and rheumatoid headache, and drowsiness. nephrotoxicity (dysuria, condition. Question history of GI
rheumatoid arthritis hematuria, proteinuria, nephrotic bleeding, gastric or duodenal ulcers,
arthritis. Occasional (3%–1%): syndrome), and severe hypertension
Stomatitis, diarrhea, hypersensitivity reaction (fever,
indigestion. chills, bronchospasm) Intervention/Evaluation
Assist with ambulation if dizziness
occurs. Periodically monitor renal
Rare (less than 1%):
function test during chronic use.
Vomiting, confusion. Monitor daily pattern of bowel
activity, stool consistency. Evaluate
for therapeutic response: relief of pain,
stiffness, swelling; increased joint
mobility, reduced joint tenderness,
improved grip strength.

Patient/family teaching
• Avoid tasks that require alertness,
motor skills until response to drug is
established.
• Take with food, milk.
• Avoid aspirin, alcohol during therapy
(increases risk of GI bleeding).
• Report headache, rash, visual
disturbances, weight gain, black or
tarry stools, bleeding, persistent
headache.